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INTRODUCTION 
The fundamental reasons and test systems available for the empiric;. screening 
of antiviral substances was discussed by Herrmann in his review published some 15 
years ago.’ Today there are a number of in vitro procedures available to investigators 
interested in antiviral chemotherapy. Herrmann and coworkers described an agar 
diffusion method for the detection and bioassay of antiviral substances.2 Plastic 
panels frequently are used for determining the cytotoxicity and antiviral efficacy of 
candidate c o m p ~ u n d s . ~ * ~  A mathematical treatment of data  derived from panel 
procedures yields a “virus rating” (VR). The VR is a measure of the inhibition of the 
virus cytopathogenic effect by a drug at levels nontoxic or partially toxic for the host 
cell. In an attempt to measure the selective inhibition of viral nucleic acid synthesis 
compared with host nucleic acid synthesis, Miller and associatess developed a 
procedure utilizing the uptake of radioisotopically labeled uridine or thymidine as a 
criterion for antiviral activity. Although each of the above procedures has been suc- 
cessfully employed in antiviral screening studies, they have not been able to uni- 
formly predict the clinical usefulness of putative antiviral drugs. 
In  previous studies on the biochemical action of the antiviral drug 9-8-D- 
arabinofuranosyladenine (ara-A),e-7 we noted that herpes simplex virus (HSV) DNA 
synthesis was inhibited to a greater degree by the drug than was host DNA synthesis. 
It is possible that the ability of ara-A to preferentially inhibit viral DNA synthesis 
may be related to the drug’s favorable therapeutic index in experimental animals8 
and man.@ Therefore, we have developed an evaluation procedure to quantitate the 
selective activity of ara-A and have applied it to the evaluation of other potentially 
useful compounds. The  procedure can be used advantageously with human 
herpesviruses and involves the mathematical determination of a value that we have 
termed the “selective index” (SI). The S I  is derived from a measurement of the 
effects of a drug on host and viral DNA synthesis by comparing 50% inhibitory (Iso) 
concentrations. A drug will have a positive SI if it inhibits viral DNA synthesis to a 
greater extent than host DNA synthesis. Conversely, a drug that inhibits host DNA 
synthesis more than viral DNA synthesis will have a negative SI. 
MATERIALS AND METHODS 
Materials 
The following drugs were obtained through the courtesy of the corresponding 
investigators: 9-~-~-arabinofuranosyladenine (a ra-A,  Vira-A@), Dr.  H. E. 
*This work was supported by Public Health Service Grant DE 02731 from the National In- 
stituteof Dental Research, and CA 16219 from the National Cancer Institute. 
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Machamer, Parke. Davis and Co., Detroit, Mich.; 1-P-D-arabinofuranosylcytosine 
(ara-C, Cytosar'"), Dr. H. E. Renis, The Upjohn Co., Kalamazoo, Mich.; 
coformycin, Dr. H. Umezawa, Institute of Microhial Chemistry, Tokyo, Japan; 
stallimycin (formerly Distamycin A), Dr. J. A. Page, Adria Laboratories, Inc., 
Wilmington, Del.; phosphonoacetic acid (PAA), Dr .  R. G. Duff, Abbott Labora- 
tories, North Chicago, Ill.: and ribavirin (VirazoleR ), Dr. R.  W. Sidwell, ICN Nu- 
cleic Acid Research Institute, Irvine, Calif. The following materials were purchased 
from the indicated sources: 9-P-~-arabinofuranosylhypoxanthine (ara-H), Pfanstiehl 
Laboratories, Inc., Waukegan, 111.; 4-(2-hydroxyethyl)-l-piperazineethanesulfonic 
acid (HEPES) and pronase, Calbiochem, La Jolla, Calif.: sarkosyl, Geigy Industrial 
Chemicals, Chicago, I l l . ;  [m~rhyI-~HHj-thymidine (dThd), New England Nuclear, 
Boston, Mass.; and CsCI, Kawecki Berylco Industries, Inc., Boyertown, Pa. 
Cell Culture Terhniques 
The source of cells and HSV Type I ,  the routine growth and passage of BHK 
21/4 cells and KB cells, the propagation and titration of HSV, and the techniques 
used for the enumeration of cells, the determination of cell viability, and the detec- 
tion of mycoplasma contamination have been described previously.fi 
Protocol for Studies in Monolayer Cultures 
K B  cells were planted in plastic tissue culture flasks (75 cm2 surface area) 
(Falcon Plastics, Oxnard, Calif.) 18 to 24 hr prior to infection with HSV. At theonset 
of experiments, logarithmically growing, replicate monolayer cultures were 60% to 
70% confluent and contained 4 to 6 x 10' cells/flask. The medium was decanted and 
the cultures were infected with 10 plaque-forming units (PFU) of HSV per cell. The 
HSV was contained in 1.0 ml of minimal essential medium with Hanks salts 
[MEM(H)] supplemented with 10% unheated calf serum. Mock-infected monolayer 
cultures received I .O ml of medium alone. After a I-hr  adsorption period at 37". the 
cell sheet was rinsed twice with 5 ml of MEM(H)  to remove unadsorbed virus and 
10.0 m1 of medium containing [3H]thymidine (dThd, 5 fiM, 2 or 3 pCi/ml), 2X 
arginine, and 10% extensively heated calf serum* was added. Drugs were added to 
the medium at  the selected concentrations immediately prior to use. Following a I2- 
or 16-hrt incubation at 37", 0.5 ml of 0.25 mM ethylenediaminetetraacetate(EDTA) 
was added to uninfected monolayer cultures and after several minutes at 37" flasks 
were shaken to suspend the cells. Infected monolayers were shaken to suspend the 
cells and 1.0 ml aliquots were removed and stored at  -76" for subsequent virus 
assay. EDTA (0.45 ml) was added to the remaining medium to bring the final 
concentration to that in the uninfected cultures. Aliquots (100 P I )  of the suspensions 
were spotted in triplicate on filter paper circles, which were processed for the de- 
termination of incorporated label as described previously.'j Data were tabulated on 
the basis of tritium incorporated into acid-insoluble material per lo5 cells. Inhibition 
of DNA synthesis was determined at the various drug levels as a percent of a control 
without drugs. Five-ml aliquots of infected cell suspensions were centrifuged at  600g 
for 5 min and the pellets stored at -76" for subsequent separation of viral and 
cellular DNA. Following isopycnic centrifugation in CsCl gradients6 the amount of 
tPrevious work in our laboratory6,' established that the synthesisofviral DNA was complete 
and drug effects were maximal 10-12 hr postinfection. 
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label was proportioned between viral and cellular DNA on the basis of peak areas. 
Areas were determined directly or by integration after the peaks were fully 
separated using a Dupont 310 curve resolver set to fit Lorentzian distribution curves. 
Statistical Analyses 
Dose-response relationships were constructed by linearly regressing probit values 
of the percent inhibition of DNA synthesis or plaque formation against log drug con- 
centrations. The 50% inhibitory (I5") concentrations and the 95% confidence intervals 
were calculated from the regression lines using the methods described by Gold- 
stein.'" Identity of any two dose-response curves was tested by calculating p values 
for the equality of the regressions and slopes." Unless otherwise noted, the slopes of 
all the pairs of dose-response curves compared in this study were similar (p > 0.350); 
consequently p values given in the text refer only to the comparison of regressions. 
RESULTS 
Inhibition of Total DNA Synthesis 
Incorporation of labeled dThd into acid-insoluble material was determined in the 
presence and absence of drugs. Incorporation of label was taken as  measure of the 
total amount of DNA synthesized by uninfected and HSV-infected monolayer cul- 
tures of KB cells. FIGURE l illustrates the inhibition of total DNA synthesis in unin- 
fected and infected cells by ara-C and ara-A plus 3.5 pM coformycin.1 Ara-C in- 
hibited total DNA synthesis in uninfected cells more effectively than it inhibited 
DNA synthesis in HSV-infected cells. This was observed a t  all drug concentrations 
tested in three separate experiments. Construction of dose-response relationships us- 
ing all values from these experiments (FIGURE 1) showed the degree of inhibition to 
be significantly different (p < 0.OOOl) in infected and uninfected cells. Interpolation 
of 50% inhibitory (I,") concentrations from these lines (FIGURE I ,  TABLE I )  indicated 
that DNA synthesis in uninfected cells was inhibited more than three times as  effec- 
tively. In contrast, no consistent differences were observed in five experiments on the 
effects of ara-A plus coformycin on total DNA synthesis. Analysis of the overall 
dose-response relationships (FIGURE I )  confirmed that the drug effect was virtually 
the same (p = 0.41) in uninfected and HSV-infected cells. Fifty percent inhibitory 
concentrations also were virtually identical for uninfected and infected cells with a 
complete overlap of the corresponding 95% confidence intervals (FIGURE 1, TABLE I). 
We previously have shown that ara-H also inhibited total DNA synthesis to the same 
extent (p = 0.69) in uninfected and HSV-infected KB cells.' Ara-A without an 
adenosine deaminase inhibitor, however, was two times more effective in inhibiting 
total DNA synthesis in HSV-infected cells (TABLE 1); the two dose-response curves 
were parallel but not coincident (p = 0.015).' 
Several other drugs have been examined in the same manner. TABLE I also sum- 
marizes the effects of these drugs, expressed as Iso concentrations, on total DNA 
synthesis (TABLE I ,  columns I & 2). PAA and stallimycin appeared to be somewhat 
more effective (45% and 78%, respectively) in inhibiting total DNA synthesis in 
HSV-infected cells compared with uninfected cells. However, the pairs of dose- 
SCoformycin at this concentration totally inhibited adenosine deaminase activity without 
affecting either viral replication or cellular and viral DNA synthesis.' 
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FIGURE I .  Dose-response relationships between drug concentration in culture medium and 
inhibition of total DNA synthesis. Mock-infected (open symbols, dashed lines) and HSV- 
infected (closed symbols, solid lines) monolayer cultures of K B  cells were exposed to [3H]dThd 
and drugs for I2 hr. Amount of label incorporated into acid precipitable material was de- 
termined in triplicate on aliquots of harvested cells. I n  the absence of drugs approximately 
20,000 or 40,000 cpm were incorporated per lo5 cells by mock-infected or  HSV-infected cul- 
tures, respectively. I,, concentrations (and corresponding 95% confidence intervals) were calcu- 
lated from the regression lines. The p values refer to a test of the equality (coincidence) of the 
pairs of regression lines. 
response curves used to calculate these concentrations were not significantly 
different (p = 0.25 and 0.13, respectively). Like ara-C, ribavirin was more potent (10- 
fold) in uninfected K B  cells than in HSV-infected cells. The two dose-response 
curves were parallel but separate (p < 0.0001). 
Inhibition of D N A  Synthesis in HSV-Infected C e h  
Lysates were prepared from all HSV-infected cultures and were subjected to 
isopycnic centrifugation in CsCl gradients to separate cellular and viral DNA. The 
effects of ara-A plus 3.5 pM coformycin (panel A )  and ara-C (panel 9) on the amount 
of [3H]dThd incorporated during 12 hr of labeling are  shown in Figure 2. As is evident 
from the figure, viral DNA synthesis was inhibited to a significantly greater extent 
than was cellular DNA synthesis by ara-A plus 3.5 pM coformycin. In contrast, ara- 
C inhibited the synthesis of both DNA species to approximately the same extent. The 
data from five ara-A and three ara-C replicate experiments are  summarized as dose- 
response curves in FIGURE 3. Ara-A plus 3.5 pM coformycin inhibited viral DNA 
synthesis three times more effectively than it inhibited cellular DNA synthesis based 
upon the difference in the dose-response curves (p < 0.OOOl)  and the difference in the 
corresponding I,, concentrations (TABLE 1, columns 3 & 4). In a previous report' we 
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TABLE 1 
INHIBITION OF DNA SYNTHESIS BY ANTIVIRAL DRUGS* 
I,, Concentration, in pM (and Corresponding 
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(165-578) 
( I  . l-3.3) 
(244-734) 
Total DNA Cellular DNA 
Synthesis in Synthesis in 
HSV-Infected HSV-Infected 
K B  Cells K B  Cells 
0.24 0.23 
(0.17-0.33) (0.14-0.39) 
4.1 8 .o 
(3.1-5.5) (6.1-10.5) 
31 67 
215 > 750 
402 583 
184 > 1500 
(47-723) ND$ 
238 67 I 
(I7 1-333) (268- 1680) 
N D t t  455 
(19-48) (34-120) 
(1 30-357) ND§ 






















PAA 1038 712 I398 485 
, (337-2202) (384- 1323) (389-5025) (307-766) 
*Performed in monolayer culture a t  a multiplicity of infection (MOI) = 10. 
tThat  range of values which, at the 95% confidence level, contains the true value. 
STaken in part from the data of Schwartz, Shipman, and Drach.' 
§Not determined accurately owing to a poor fit ( r2  5 0.3) of data points to dose-response 
qFormerly designated Distamycin A. 
**Calculated from the data of Pelling and Shipman.12 
t t N o t  determined. 
curve. 
established that both ara-A (without coformycin) and ara-H also were three times 
more effective as inhibitors of viral DNA synthesis (TABLE 1). In comparison, ara-C 
inhibited neither cellular nor viral DNA synthesis preferentially (p = 0.39, FIGURE 
3). Examination of individual gradients showed, however, that in all experiments ara- 
C concentrations 5 0.2 pM inhibited cellular DNA synthesis in slight preference to 
viral DNA synthesis, whereas a t  concentrations greater than this the opposite was 
true (FIGURE 2).  
Similar experiments have been performed to evaluate the effects of PAA, ri- 
bavirin, stallimycin, and 2,3-dihydro-lH-imidazo[l,2-b]pyrazole ( IMPY).  The 
activity of the last compound against HSV has been reported by Pelling and 
Shipman.'* The first three compounds all produced a greater inhibition of viral DNA 
synthesis than of cellular DNA synthesis. Stallimycin was approximately 3-fold more 
potent in this regard. However, variation in the degree of inhibition of cellular DNA 
synthesis observed in duplicate experiments resulted in some overlap of 95% confi- 
dence intervals (TABLE I )  and a degree of identity between the two dose-response 
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curves (p = 0.1 I ,  data not shown). More pronounced variations in the effects of PAA 
and ribavirin on cellular DNA synthesis (TABLE 1 )  make exact comparisons o f  the I,, 
concentrations difficult--even though cellular DNA synthesis appears to be much 
less sensitive to the two drugs than does viral DNA synthesis. IMPY affected the 
synthesis of the two DNA species in an opposite manner. This compound was 68% 
more potent in  its inhibition of cellular DNA synthesis. The two dose-response 
curves used to calculate I,, concentrations were not coincident (p = 0.003, data not 
shown). 
Calculation ofthe Seleclive Index 
I n  the preceding sections we have compared drug effects on total DNA synthesis 
and on separated cellular and viral DNA synthesis. We believe, however, that the 
F I G U R E  2. Separation of viral and cellular DNA from HSV-infected cells by isopycnic centri- 
fugation in CsCl gradients. Amount of label incorporated into cellular and viral DNA was 
measured in the absence and presence o f  ara-A plus 3.5 pM col'ormycin (panel A )  and ara-C 
(panel B). The amount is expressed as  a percentageof the amount incorporated into the respec- 
tive DNA species in cultures without drugs. 
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(Plus Coformycin) 
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FIGURE 3. Dose-response relationships between drug concentration in culture medium and 
inhibition of DNA synthesis in HSV-infected cells. DNA was labeled in the experiments 
depicted in FIGURE I and separated as illustrated in FIGURE 2. The amount of [3H]dThd incor- 
porated into cellular DNA (open symbols, dashed lines) and viral DNA (closed symbols, solid 
lines) is expressed as a percentage of the amount incorporated into the respective DNA species 
in the absence of drugs. I,, concentrations and p values were determined as described in the 
legend to FIGURE 1. 
most valid comparison is between the effects of drugs on DNA synthesis in 
uninfected cells and the effects on viral DNA synthesis in HSV-infected cells. To aid 
in this comparison and to more clearly define the relationship, we have derived an 
index that quantifies the preferential inhibition of viral or uninfected cellular DNA 
synthesis. The I,, concentration of a drug for DNA synthesis in uninfected cells is 
divided by the 15, concentration for viral DNA synthesis. We have termed the 
logarithm of this ratio the “selective index” (SI). That is, 
16, concentration for DNA synthesis in uninfected cells 
I,, concentration for viral DNA synthesis in HSV-infected cells 
SI = log,, 
The S1 is positive if viral DNA synthesis is inhibited preferentially and negative if 
uninfected cellular DNA synthesis is more strongly inhibited. 
SI values were calculated for the drugs evaluated in this study from the data 
listed in TABLE I (columns I & 4). TABLE 2 ranks these drugs according to their SI. 
Ara-A plus coformycin, ara-A, ara-H, PAA, and stallimycin were positively selective 
whereas ara-C and ribavirin were negatively selective.§ The coincidence of the two 
dose-response regression lines (from which the component I,, values were calcu- 
$To simplify descriptions, we have termed drugs that preferentially inhibit viral DNA syn- 
thesis as “positively selective” and drugs that preferentially inhibit host cell DNA synthesis as 
“negatively selective.” 
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TABLE 2 
A N D  HSV-INFECTED; MONOLAYER CULTURES OF K B  CELLS 
SELECTIVE INDICES OF DRUGS EVALUATED IN UNINFECTED 














Stallimycin, PAA, ara-A+t 
Ara-C 
- 1.9 Ribavirin 
*MOI (multiplicity of infection) = 10. 
tAra-A+ = ara-A plus 3.5 p M  coformycin. 
lated) was tested by comparing p values for the equalities of the slopes and 
regressions of the two lines. The pairs of dose-response regression lines for ara-C, 
ara-A plus coformycin, ara-A, ara-H, and stallimycin were parallel (the slopes were 
similar, ~ 5 0 . 3 ) .  With the exception of stallimycin, the regressions were different (the 
parallel lines were defined by separate regressions, p 5 0.05). For example, the 
dashed line in FIGURE 1 for ara-C was parallel to, but separate from, the solid line in 
FIGURE 3. On the other hand, the pairs of dose-response lines for PAA and ribavirin 
were not parallel (p < 0.005) and therefore not coincident. 
Eflect of Cell Propagation Method on SI 
In a previous communication7 we reported that ara-A and ara-H were more se- 
lective in suspension cultures than in monolayer cultures. This was the result of a 
greater inhibition of viral DNA synthesis in HSV-infected cells grown in suspension 
culture. We speculated that the cause was a less efficient adsorption of HSV than 
had occurred in monolayer cultures. We now have tested this speculation by evalua- 
ting ara-H in monolayer cultures infected with HSV at  a multiplicity of infection 
(MOI) of 1 rather than 10. The selectivity of ara-H was increased to 1.0 in monolayer 
cultures infected at a MOI of 1 (TABLE 3). This was the result of an increase in the 
drug sensitivity of viral DNA synthesis and not of a change in the drug sensitivity of 
DNA synthesized in uninfected K B  cells (TABLE I ) .  
Inhibition of HSV Replication 
The effect of drugs on HSV replication in K B  cells was measured by assaying in 
BHK-2114 cells the number of plaque-forming units of newly synthesized virus. Dose 
response relationships were constructed for each drug (data not shown) and com- 
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TABLE 3 
SELECTIVE INDICES OF DRUGS EVALUATED 
UNDER VARIOUS CULTURE CONDITIONS 
Method of Cell 
ProDaeation Drug MOI Selective Index 
Suspension Ara -At*  3 0.7t 
Ara-H 3 0.6t 
Synchronized Suspension Ara-A 15 1.11 
Ara-H 15 1.11 
Monolayer Ara-A 10 0.5 
Ara-A+* 10 0.3 
Ara-H 10 0.4 
Ara-H I 1 .O 
*Am-A + = ara-A plus 3.5 pM coformycin. 
$Calculated from the data of Schwartz et al.’ 
$Calculated from the data of Shipman el al.a 
pared with the  corresponding relationships for inhibition of viral DNA synthesis. 
TABLE 4 illustrates tha t  there  was close correspondence between t h e  Isa concentra- 
tions for viral DNA synthesis and the  I a o  concentrations for HSV replication. With 
the exception of stallimycin, the  pairs of dose-response lines used to  calculate t he  re- 
spective Is0 concentrations were nearly coincident (p  > 0.25). Stallimycin appeared 
to inhibit HSV replication to a slightly greater extent than it inhibited viral DNA 
synthesis. 
TABLE 4
1NHlBlTlON OF HSV REPLICATION BY ANTIVIRAL DRUGS 
I,,,  Concentration, in p M  (and Corresponding 
95% Confidence Interval) 
Viral DNA HSV 
Drug Synthesis* Replication Pt 
Ara-C 0.2 I 0.19 0.30 
Ara-A plus 2.6 2.1 0.27 
Ribavirin I45 I23 0.64 
(0.15-0.30) (0.13-0.26) 
3.5 pM coformycinf (2 .O- 3.3) ’ (1.0-4.6) 
( 1 1 1  191) (50 302) 
Stallimycin 206 I42 0.0 1 
(I30 -327) ( 103- 194) 
(307-766) (293- I 137) 
PAA 48 5 517 0.83 
*Presented also in TABLE I .  
tDose-response regression lines for inhibition of viral DNA synthesis were compared to the 
corresponding lines for inhibition of HSV replication by calculating p values for the equality of 
the slopes and regressions of the two lines. The slopes of each pair of lines for the listed drugs 
were virtually the same ( p  2 0.5), consequently the p value in the table refers only to a com- 
parison of regressions. 
$Calculated from the data of Schwartz et al.’ 
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DISCUSSION 
The biochemical method described herein has been used to evaluate the specifc- 
ity of drug action on host cell and viral DNA synthesis. The method is proposed not 
as a primary screening technique [or antiviral drugs but rather as an additional, more 
specific test of drugs found active in the more routine in vilro Together, in- 
formation derived from both procedures could be valuable in predicting drug efficacy 
and toxicity in vivo. That is, positively selective drugs that are  active against DNA 
viruses might be expected to cause less cytotoxic manifestations in vivo (e.g., 
depression of immune mechanisms, bone marrow, etc.) than drugs that are nega- 
tively selective. Although we have utilized only HSV Type 1 in the current study, the 
method should be applicable to any herpesvirus whose DNA can be separated from 
host cell DNA by isopycnic centrifugation. This would include HSV Type 2, 
cytomegalovirus, Epstein-Barr virus, and possibly varicella-zoster virus.I3 
Other biochemical methods have been utilized for the evaluation of antiviral 
agents. Miller et al.” developed a method to detect compounds that were selective in- 
hibitors of viral RNA synthesis. Calculation of I,,, concentrations permitted a direct 
comparison of drug effects on RNA synthesis in uninfected cells and viral RNA syn- 
thesis in infected cells. (Actinomycin D was used to block host RNA synthesis in 
infected cells.) The method was extended to DNA viruses by digesting unincapsi- 
dated DNA with DNAse. De Clercq and ShugarI4 also used a comparison of I,, con- 
centrations to calculate “antiviral indices.” Inhibition of dThd incorporation or 
growth of uninfected cells was compared to inhibition of vaccinia-virus-induced cy- 
topathogenicity . 
I n  the present study we have concluded that the best measure of a drug’s se- 
lectivity should be based upon a comparison of drug efects  as described i n  our defini- 
tion of the SI, namely, a comparison of the inhibition of DNA synthesis in uninfected, 
logarithmically growing cells to inhibition of viral DNA synthesis. This appears to 
best approximate the in vivo situation where a drug will exert its antiviral effect based 
on inhibition of viral DNA synthesis in the infected cell and will cause toxic effects on 
uninfected proliferating cells at sites that may be remote to the viral infection. We 
rejected the more simple comparison of drug effects on total DNA synthesis in 
uninfected and HSV-infected cells as the sole measure of selectivity because host cell 
DNA synthesis contributes to the latter measurement. The exact nature of cellular 
DNA in HSV-infected cells and the control of  its synthesis is somewhat unclear, and, 
as judged from the variability of inhibition (see confidence intervals, TABLE I ,  column 
3), drug effects are  more difficult to quantitate. That is not to say, however, that 
effects on host cell DNA synthesis in infected cells should be ignored. As is evident in 
FIGURE 2, the selectivity expressed by ara-A plus coformycin is most readily 
discerned by comparison with cellular DNA synthesis within the infected cells. 
Our choice of the 50% inhibitory concentration as  the basis for comparing drug 
effects may complicate the interpretation of selectivity in some instances. If dose- 
response curves are parallel the I,,, concentration is simple to determine and will 
yield the same SI as would the 10% or 90% inhibitory concentrations. However, if 
dose-response curves are not parallel, as was the case with ribavirin and PAA, then 
the choice of any inhibitory concentration as the basis of comparing the two curves 
may be improper. I n  the latter case comparisons based on the slopes of the lines 
might be more valid, Fortunately, in the case of PAA and ribavirin the interpretation 
was the same on either basis o f  comparison. 
The additional possibility that we did not measure drug action on DNA synthesis 
must be considered. I n  this and our prior articles6~’ the incorporation of [3H]dThd 
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into acid-precipitable material has been equated with DNA synthesis. We have not 
ruled out the possibility, however, that the noted selective effects were the result of 
differential changes in the specific activity of [SH]dThd nucleotides, which might ac- 
company drug treatment or HSV-infection. In fact, it has been known for a number 
of years that HSV-infection increases dThd nucleotide pools in mammalian  cell^.'^*^^ 
However, for this increase to influence the reported selectivities (both positive and 
negative) pool sizes in uninfected and HSV-infected cells also would have to change 
independently with changes in drug concentration. Although we have no data for 
most of the drugs studied, we have observed that 120 pM ara-A did not alter the la- 
beling of dThd nucleotides in B-mix K-44/6 cells (unpublished observation). 
Moreover, to attribute the preferential inhibition of viral or cellular DNA synthesis 
within the infected cell to drug-related pool size changes requires that viral and 
cellular DNA be synthesized from separate dThd nucleotide pools in the nuclei of 
HSV-infected cells. Also these pools would have to change independently with drug 
concentration changes. In addition, the close correspondence between inhibition of 
viral DNA synthesis and inhibition of HSV replication (TABLE 4) argues that, for the 
drugs tested, inhibition of [3H]dThd incorporation into viral DNA is a fair measure of 
inhibition of viral DNA synthesis. Nonetheless, experimental determination of nu- 
cleotide pool sizes or specific activity of [3H]dThd incorporated into DNA will be re- 
quired to totally resolve the issue. 
I f  drug-induced pool size changes do alter the SI, the alteration most likely would 
be with those drugs whose selectivity arose from differential inhibition of total DNA 
synthesis-such as ara-C (FIGURE 1) or ribavirin. In the case of ara-C, however, it is 
interesting that our results are in accord with those of Kaplan and B e n - P ~ r a t ' ~ * ' ~  who 
also observed a preferential inhibition of DNA synthesis in uninfected rabbit kidney 
cells compared to HSV- or PRV-(pseudorabies virus)-infected cells. These investiga- 
tors concluded that ara-C was not a specific antiviral agent. The accord between the 
two sets of data is particularly noteworthy because our experiments were performed 
with HSV, which increases dThd nucleotide pool ~ i z e , ' ~ . ' ~  and theirs with PRV, which 
does In contrast, Sidwell and H~ffman~concluded  that ara-C possessed a high 
degree of antiherpes activity having a VR greater than that of ara-A (1.3 compared 
with 1.1). Our results with ribavirin also differ with those of Huffman and 
coworkers.20 The antiviral activity of the drug appears lower in our KB cells = 
123 pM, TABLE 4) than in theirs [minimum inhibitory concentration (MIC) = 4.1 
pM], but direct comparisons between ls0 values and MIC values may be misleading. 
Of more concern is the potent inhibition of DNA synthesis we observed with ribavirin 
in uninfected KB cells (Iso = 1.9 pM) compared with a relative lack of cytotoxicity 
measured microscopically by Huffman et a/.20 Although drug-induced changes in 
dThd nucleotide pool sizes or use of logarithmically growing cultures of KB cells 
(compared with Sidwell and associates' use of stationary may account 
for the noted differences, we have no data to support either possibility. On the other 
hand, the observation that ribavirin exhibited negative selectivity when examined in 
the usual manner (TABLE I ,  columns 1 & 4) but showed positive selectivity against 
viral DNA synthesis within HSV-infected cells (TABLE 1, columns 3 & 4) may be re- 
lated to the known cell line specificity of this drug.20-2' 
The selective inhibition of viral DNA synthesis compared with cellular DNA 
synthesis has been noted with other inhibitors. Becker and WeinbergZ2 have reported 
that a concentration of 96.5 p M  stallimycin completely inhibited the synthesis of 
viral DNA but only partially reduced the amount of cellular DNA. The effects of this 
drug were not as potent in the current study (TABLE I ,  column 4). Furthermore, we 
observed a progressive decrease in the bouyant density of viral and cellular DNA 
synthesized in the presence of increasing drug concentrations. This indicates that 
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even though cellular DNA was synthesized, it may not have been able to function 
normally. Phosphonoacetic acid similarly has been shown to selectively inhibit the 
synthesis of HSV DNA.23 Although we did not observe the nearly total selectivity 
against viral DNA synthesis (TABLE 1, columns 3 & 4) noted previouslyz3 the two sets 
of data probably can be reconciled by Overby and associates' use of confluent cul- 
t u r e ~ . ~ ~  In  fact, our results agree in general with those of Overby et al.23 and Huangz4 
who found that concentrations of PAA required to totally block viral DNA synthesis 
also partially inhibited DNA synthesis in logarithmically growing, uninfected cells. 
This observation is consistent with DNA polymerase 0 being insensitive to the drug, 
whereas DNA polymerase a! has equalz5 or lesserZ6 sensitivity than does HSV DNA 
polymerase. Schildkraut et aLZ7 have reported the selective inhibition of HSV rep- 
lication by 5-bromodeoxycytidine and 5-iododeoxycytidine. The selective action ap- 
pears to be dependent upon a virus-induced enzyme that catalyzed the conversion of 
the halogenated analogues of deoxycytidine to the corresponding nucleotides. Zinc 
ions also have been found to inhibit the replication of HSV.28 Inhibition appears to be 
a consequence of the selective blockage of viral DNA synthesis through the inhibition 
of HSV DNA polymerase. Prusoff and c011eagues~~ recently reported on the selec- 
tive inhibition of HSV by 5'-amino-2',5'-dideoxy-5-iodouridine (AIU). Again, the high 
selectivity of AIU for HSV-infected cells probably is related to the specificity of a 
HSV-induced enzyme. I n  contrast, a selective inhibition of cellular DNA synthesis in 
HSV-infected and Epstein-Barr virus-infected cells has been reported with 
cordycepin3" and with hydroxyurea.sl 
SUMMARY 
A cell culture system has been utilized to measure the effects of drugs on DNA 
synthesis in uninfected and HSV-(herpes simplex virus)-infected KB cells. DNA 
from HSV-infected cells was separated into viral and cellular components by 
isopycnic centrifugation in CsCl gradients. The amount of [3H]thymidine incor- 
porated into acid-insoluble material was measured in the absence and presence of 
drugs. Dose-response relationships were established by linearly regressing the probit 
value of the percent inhibition of DNA synthesis against the logarithm of drug 
concentration. Fifty percent inhibitory (1s")  concentrations were interpolated from 
the corresponding regression lines for inhibition of the following: (i) DNA synthesis is 
uninfected K B  cells, (ii) total DNA synthesis in HSV-infected KB cells, (iii) cellular 
DNA synthesis in HSV-infected cells, and (iv) viral DNA synthesis in HSV-infected 
cells. 
We have derived an index (SI, selective index) that quantifies the preferential in- 
hibition of viral or uninfected cellular DNA synthesis. This index can be expressed as 
I,, concentration for DNA synthesis in uninfected cells 
1," concentration for viral DNA synthesis in HSV-infected cells 
SI = log,, 
The SI is positive if viral DNA synthesis is inhibited preferentially and negative if 
uninfected cellular DNA synthesis is.more strongly inhibited. 
A positive SI value of 0.5 was obtained for the clinically useful antiviral drug 
arabinosyladenine (a ra-A)  and a value of  0.4 fo r  its metabol i te ,  
arabinosylhypoxanthine (ara-H). Although the adenosine deaminase inhibitor 
coformycin greatly increased the potency of ara-A, the inhibitor did not increase the 
selectivity of the drug (SI = 0.3). Stallimycin (distimycin A) (SI = 0.3) and phos- 
phonoacetic acid (SI = 0.3) were similarly effective in preferentially inhibiting the 
408 Annals New York Academy of Sciences 
synthesis of HSV DNA. In contrast, arabinosylcytosine (ara-C) and ribavirin in- 
hibited DNA synthesis in uninfected cells to a greater degree than viral DNA syn- 
thesis (SI = -0.5 and - 1.9, respectively). 
An analysis of the advantages and limitations of this experimental procedure is 
made and the suggestion is offered that the in vitro determination of a drug’s selec- 
tive index may be a valid predictor of clinical usefulness. 
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